根治性治疗对未破裂脑动脉瘤破裂率的影响:竞争风险生存分析
该回顾性研究纳入722例未破裂脑动脉瘤患者,采用竞争风险生存分析评估破裂累积发生率。至2014年,19例发生破裂,总体破裂率为每年0.57%(3320.8人年),2年内累积破裂发生率为1.3%,同期38.4%患者接受根治性治疗。动脉瘤>5 mm、位于前或后交通动脉及形态不规则与破裂相关。
要点
- 未破裂脑动脉瘤总体破裂率为每年0.57%(3320.8人年),2年内累积破裂发生率为1.3%。
- 同期38.4%患者接受根治性治疗,竞争风险分析可避免低估破裂率。
- 动脉瘤>5 mm、前或后交通动脉位置及不规则形态与破裂相关,HR分别为4.4、3.5、2.1。
核心结论
- 使用人年或标准Kaplan-Meier法分析破裂率而不考虑竞争风险信息量不足,破裂发生率应同时呈现竞争风险事件。
研究设计与样本
- 回顾性分析2000至2009年一家机构电子病历和电话访谈诊断的722例未破裂脑动脉瘤患者,采用竞争风险生存分析评估破裂累积发生率,并用回归分析评估破裂相关因素。
主要发现
- 至2014年,19例患者发生动脉瘤破裂,总体破裂率为每年0.57%(3320.8人年)。
- 累积发生率分析显示,2年内1.3%的患者发生破裂,同期38.4%的患者接受根治性治疗。
- 回归分析显示,动脉瘤大小>5 mm、位于前或后交通动脉及形态不规则与破裂相关,HR分别为4.4(95% CI 1.2-15.7)、3.5(95% CI 1.4-8.7)、2.1(95% CI 0.7-6.0)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the risk of bleeding from unruptured cerebral aneurysms (UCAs), previous studies have used Kaplan-Meier analyses without treating the definitive treatment as a competing risk event, which may underestimate the rupture rate. The authors analyzed the survival of patients with UCAs alongside the occurrence of aneurysm bleeding and its competing risk events. METHODS: A retrospective analysis was conducted on 722 patients diagnosed with UCAs in the period from 2000 to 2009 using an institution's electronic medical records and telephone interviews. The cumulative incidence of aneurysm rupture was examined, and factors contributing to rupture were assessed using regression analyses. RESULTS: By 2014, 19 patients had experienced aneurysm rupture, with an overall rupture rate of 0.57% per year over 3320.8 person-years. However, cumulative incidence analysis indicated that 1.3% of all patients had a rupture within 2 years after aneurysm identification, and 38.4% of the patients underwent definitive treatment in the same period. Among the patients who experienced rupture, regression analysis revealed that an aneurysm size greater than 5 mm, a location in the anterior or posterior communicating arteries, and an irregular shape contributed to aneurysm rupture, with HRs of 4.4 (95% CI 1.2-15.7), 3.5 (95% CI 1.4-8.7), and 2.1 (95% CI 0.7-6.0), respectively. CONCLUSIONS: Rupture rate analyses using the person-year or standard Kaplan-Meier method are not as informative without consideration of the competing risks. The incidence of aneurysm rupture should be presented clearly with those of competing risks.
引用
- Kimura T, Ochiai C, Kawai K, et al. How definitive treatment affects the rupture rate of unruptured cerebral aneurysms: a competing risk survival analysis. J Neurosurg. 2019. PMID: 30849750. doi:10.3171/2018.11.JNS181781
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。